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ABSTRACT
Natto is a traditional Japanese food prepared from fermented soybeans. nattokinase (NK) is considered one of the most active functional ingredients in natto. The present study evaluated the neuroprotective effects of NK in gerbils subjected to focal cerebral ischemia.
The gerbils were separated into four groups: control group, ischemic group and two NK groups (4 and 40 mg/day i.g. for 7 days). All gerbils
were fed standard chow with or without NK prior to cerebral ischemia. Focal cerebral ischemia was induced by the occlusion of the right
common carotid artery and middle cerebral artery for 60 min, followed by reperfusion. Infarct volumes were determined by 2,3,5-triphenyltetrazolium chloride staining. Anti-thrombotic effects of NK, such as fibrinogen, prothrombin time and activated partial thromboplastin
time, were also determined. Our data showed that NK significantly reduced infarct volumes by 54-68% (p < 0.01), compared to the ischemic group. Prothrombin time was not significantly different in all groups. However, low dosage NK (4 mg/day) reversed ischemic-induced
increase in fibrinogen concentrations and activated partial thromboplastin time. In summary, the data indicated that oral intake of NK for
7 days may alter fibrinolytic activity and provide neuroprotective effects against focal cerebral ischemia in gerbils.
Key words: cerebral ischemia, gerbil, nattokinase, 2,3,5-triphenyltetrazolium chloride

INTRODUCTION
Extracts of fermented soybeans (Natto), a traditional
Japanese diet, promote fibrinolytic activity in the circulation
in a similar manner to oral urokinase(1-2). A major component
from natto is nattokinase (NK). NK is a single polypeptide
chain composed of 275 amino acid residues (molecular
weight of 27,724 Da) and exhibits a high homology with
subtilisins(1,3-4). In recent studies(2,5), natto and NK were used
as traditional medicine for heart and vascular diseases, and
as anti-beriberi agents. After the oral administration of NK,
lysis of thrombi in induced-thrombosis dogs was observed
by angiograpy(2). NK also demonstrated strong fibrinolytic
activity in the digestion of fibrin and plasmin substrates(5).
Previous studies concluded that NK is one of the most
potent fibrinolytic enzymes in traditional fermented soybean
* Author for correspondence. Tel: +886-4-23592525 ext. 4018;
Fax: +886-4-23592705; E-mail: vc1035@gmail.com

food. In general, the fibrinolytic activity of NK was measured
by clot-lysis assay and compared with that of plasmin(2-3,5).
NK had about 4 times the activity of plasmin. Previous
studies demonstrated that oral administration of natto and
NK not only hydrolyzed thrombi in vivo, but also converted
plasminogen to plasmin(2,5). In addition, NK can improve
fibrinolysis for long periods of time and this is related to the
tissue plasminogen activator (t-PA) acting as an endogenous
plasminogen activator(1).
Over decades, various fibrinolytic agents such as urokinase and t-PA have been developed for thrombolytic therapy
in routine clinics. However, the biological activity of these
substances is short-lived in the body’s circulation. Sumi and
his colleagues claimed that NK has higher fibrinolytic activity
than others; it could be retained in the blood for more than 3 h
upon oral administration(2,5) . These results suggest that NK
may be a potent natural agent for oral thrombolytic therapy.
Cerebral ischemia results from limited availability of
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oxygen and glucose supply. It impairs oxidative metabolism
in severely ischemic regions of the affected brain tissues
and leads to rapid decrease in ATP and other energy-related
metabolites(6-8). Various ATP-driven membrane-bound pumps
or reuptake processes that work to maintain the homeostasis
of important metabolites or ions become impaired in brain
tissues. Moderate to severe neuronal damage might occur
following ischemic events. Several models of focal ischemia
have been developed to study the pathology and treatment
of ischemic stroke in different animal species. In one widely
used technique, cauterization or clipping of the middle cerebral artery in mice or gerbils through a subtemporal craniectomy is generally accepted as a valid experimental model of
cerebral ischemia(9-12).
In the present study, the effects of NK against cerebral
ischemia were investigated in a gerbil stroke model. The
roles of thrombolytics in the pathogenesis of cerebral ischemic reperfusion injury have been studied extensively(10-11).
Although fibrinolytic activity after the oral administration of
NK had been reported in vascular diseases, there remains a
need to explore its protective effects on the central nervous
system. In addition, plasma fibrinolytic activity after the oral
intake of NK for 7 days was also investigated in gerbils.

MATERIALS AND METHODS
I. NK and Animals
NK with a molecular mass of 27.7 kDa was isolated from
bacteria Bacillus Subtilis natto and purified by gel filtration chromatography. NK was identified by high resolution
mass spectrometry (20,000 FU/g, Synmax, Taipei, Taiwan).
The fibrinolysis unit (FU) was determined by the method of
Fujita(3), which employed a standard fibrin plate. In order to
determine the neuroprotective effects of NK as an anti-ischemic agent in vivo, a focal cerebral ischemic gerbil model was
adopted. Adult male gerbils (n = 42, 60-75 g) were obtained
from the Laboratory Animal Center of Taichung Veterans
General Hospital. All animals were housed at a temperature
of 25°C in a light-controlled room (12 : 12 h light-dark
cycle) with standard rat chow and water ad libitum. Animal
care and experimental procedures were approved by the
Institutional Animal Care and Use Commettee (IACUC) of
TCVGH (#La-97477). The gerbils were randomly separated
into two experiments. One experiment (n = 18) was evaluated based on 2,3,5-triphenyltetrazolium chloride (TTC)
staining and the other experiment (n = 24) was subjected to
blood sampling for bioassays. All gerbils were divided into
four groups: group 1 (control group with sham-operated) was
only pretreated with saline, group 2 (ischemia group) was
pretreated with saline and subjected to cerebral ischemia,
group 3 (LNKI group) was pretreated with low dosage NK (4
mg/day for 7 days; i.g.) and subjected to cerebral ischemia,
group 4 (HNKI group) was pretreated with high dosage NK
(40 mg/day for 7 days; i.g.) and subjected to cerebral ischemia, according to experimental protocol.

II. Stroke Model in Gerbils
Each gerbil was anesthetized with chlorohydrate (400 mg/
kg, i.p.) and its body temperature was maintained at 37°C
with a heating pad (CMA/150). A midline neck incision was
made and the right carotid artery was exposed and separated
from the vago-sympathetic trunk. The right carotid artery was
loosely encircled with a 4-0 suture for later occlusion. The
gerbil’s head was placed in a stereotaxic frame (David Kopf,
CA, USA) with the nose bar positioned 4.0 mm below the
horizontal line. Following a midline incision, the skull was
partially removed to expose the right middle cerebral artery
(MCA). The MCA was loosely encircled with an 8-0 suture
for later occlusion. A focal cerebral ischemia was induced by
occlusion of the right common carotid artery (CCA) and MCA
for 60 min, followed by reperfusion(12). Twenty-three hours
after cerebral ischemia, each gerbil was anesthetized and
perfused transcardially with 2% isotonic heparinized saline.
III. 2,3,5-Triphenyltetrazolium Chloride (TTC) Staining
The brain was then removed and sliced into five
2-mm-thick coronal sections for TTC staining as described by
Bederson et al.(13). The brain slices were immersed in a 2%
solution of TTC in normal saline for 20 min. They were then
washed and immersed in 10% phosphate-buffered formalin
in the dark and refrigerated until photographed. Infarct size
was determined on projected tracings normal and infarct area
of the same TTC stained section by computer image analysis.
In general, TTC staining effectively detected areas of infarction 24 h after the onset of cerebral ischemia.
IV. Measurement of Coagulation Function
After feeding either with or without NK for 7 days, all
animals received cuts 4 mm from the tail end under general
anesthesia with isoflurane. The tail was soaked in saline
1 cm from the cutting point at 37°C. Blood samples were
obtained into heparinized microtubes. After collection,
bleeding can be stopped by gently compressing the wound for
a few seconds. Plasma samples were separated, frozen and
stored at -80°C until assays were performed. For all clotting
tests, Dade reagents, Innovin and Actin FSL and Fibrinogen
(Siemens Healthcare Products GMbH, Marburg, Germany)
were used and assayed according to our medical laboratory
standard instructions. Prothrombin time (PT) determination
was performed in 50-µL plasma samples and 100 µL of
Dade Innovin (containing thromboplastin, calcium, buffers
and stablizers). The coagulation cascade was activated by
incubating plasma with the optimal thromboplastin and
calcium. The clotting time was then measured. Activated
partial thromboplastin time (APTT) was assessed using the
Dade Actin FSL reagent containing phospholipid. Dade Actin
FSL (100 µL) was added to the plasma samples (50 µL). The
mixture was incubated at 37°C for 120 s, and 50 µL of 0.02 M
CaCl2 was added to activate the reaction. Clot formation was
the end point of the reactions and the results were reported in
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Figure 1. Typical image of 2-mm thick brain slices stains with TTC after 23 h of 1 h MCAO+CCAO in gerbils. Pretreatments with saline, low and
high dosage of NK (4 and 40 mg/day; i.g.) were given for seven days prior to the MCAO+CCAO.

V. Statistical Analysis
All data are expressed as the mean±SEM. The statistical significance of differences between two groups was
determined by Student’s t-test. A p value less than 0.05 is
considered significant.

RESULTS AND DISCUSSION
I. Effect of NK on Cerebral Ischemia
All animals had infarction in the cortex and some severe
cases in the caudate-putamen. Typical infarct sizes (as visualized in white by TTC staining) in brain slices for each group
were shown in Figure 1. Mean total infarct sizes (expressed
as volumes and percentages of the right hemisphere) in the
ischemia, LNKI and HNKI groups were 79.4 ± 6.8 mm3 (15.3
± 1.2%), 36.6 ± 7.9 mm3 (7.5 ± 1.6%) and 25.2 ± 10.4 mm3
(5.0 ± 2.0%), respectively, as shown in Figure 2. Pretreatments with 4 mg and 40 mg of NK for seven days significantly reduced infarct sizes by 53.9 and 68.3% (p < 0.01),
respectively, when compared with that of the ischemia group.
In general, the occlusion of MCA and CCA does not
always result in a predictable infarction volume in animal
studies. Collateral pathways in different species may redistribute blood flow sufficiently to prevent infarction in particular regions. In rats, cats and dogs, a simultaneous occlusion
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seconds. Fibrinogen (FIB) can be converted from a soluble
protein to an insoluble polymer by the action of thrombin
resulting in the formation of a fibrin clot. Bovine thrombin
(25 µL, 100 IU/mL, Dade Fibrinogen reagent) was added to
the plasma samples (50 µL) to induce an insoluble polymer
for the fibrinogen measurement at 660 nm(14).
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Figure 2. Effects of NK on the infarct volume in gerbils. Infarct
volumes were determined by TTC staining in gerbils subjected to 1 h
MCAO+CCAO, followed by reperfusion for 23 h. Pretreatments with
NK (4 mg/day for LNKI and 40 mg/day for HNKI; n = 6 for both)
were given for seven days prior to the MCA+CCA-occlusion. Data
are expressed as mean + SEM. ** p < 0.01 for infarct volumes vs. the
control group (n = 6) as determined by Student’s t-test.

of a unilateral MCA and CCA is known to result in ischemic
infarcts of various sizes and degrees. In rats, there is a need
to occlude both the right and left CCA and one of MCA to
produce predictable infarctions. However, the gerbil brain
lacks the connection between the carotid and vertebrobasilar
circulation, resulting in an incomplete circle of Willis. Therefore, the occlusion of unilateral CCA and MCA in gerbils
was proposed in the present study. The results of this study
demonstrated that a consistent infarction volume (15.3 ±
1.2%) can be achieved 23 h after the occlusion of unilateral
CCA and MCA in gerbils. Our results are less severe but
consistent with previous studies that utilized MCA occlusion
or endovascular sutures(9-11). The experimental models of
cerebral ischemia developed by Baskaya et al.(9), Yamamoto
et al.(10) and Yoshimine et al.(11) were successful because of
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incomplete anastomosis in gerbils. The advantages of the
present model include simple craniectomy procedures and
consistent infarct volume.
II. Effect of NK on Coagulation Function
There was no difference in the PT values among all groups
as shown in Figure 3A. The APTT value was significantly
higher in the ischemia (127% of the basal) and HNKI (128%
of the basal) groups than that of the control group (Figure
3B). The FIB concentration was significantly increased in the
ischemia (173% of the basal) and HNKI (164% of the basal)
groups and was significantly decreased in the LNKI (72% of
the basal) group when compared to that in the control group
(Figure 3C).
The PT and APTT were used to reflect the extrinsic and
intrinsic coagulation pathways, respectively. Particularly,
PT is a sensitive monitoring test for patients with hereditary,
acquired coagulation disorders and using oral anti-coagulant
therapy. A recent study discovered that natto extract (16 mg/
day for 7 days) had anti-thrombotic effects that included
increasing 17% PT and decreasing 16% FIB values with direct
administration to rats subjected to sciatic nerve injury(14).
However, it had only a little effect on APTT in rats(14). In
sciatic nerve injury, thrombi formation after endothelial injury
was correlated with intimal thickening and it was found that
combination of a t-PA and an anti-platelet agent inhibited
mural thrombi formation after endothelial injury. Our recent
experimental data showed that the PT values had no significant change after cerebral ischemia. These differences in PT
might depend on different animal models and various cerebral
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ischemic insults, as well as dosages (4 mg and 40 mg/day) of
NK therapy. Further investigation will be needed to explore
the mechanisms of PT during cerebral ischemia.
Thrombolytic therapy is one of the important advances
in the management of acute ischemic stroke and is evaluated
in several randomized trials(15). NK was indicated as a potent
natural agent for oral fibrinolytic therapy. In the present
study, APTT and FIB levels were increased by 17% and 16%,
respectively. Both APTT and FIB levels were significantly
decreased in the LNKI group than those of the ischemia group
(Figure 3B & C). In the low dosage NK group, APTT and
FIB levels were reversed and even down to approximately
40% of the ischemic gerbils. APTT and FIB levels might be
indicating that a hypercoagulable state existed in cerebral
ischemic gerbils.
Fibrinogen (FIB) is a marker of coagulation and inflammation, and also influences fibrinolysis. NK is now widely
used as a health-promoting food for reducing the risk of thrombosis due to its fibrinolytic activity(1-5,16). Increased plasma
FIB levels may be associated with cardiovascular diseases(17)
and NK decreased plasma levels of FIB in a clinical trial(18).
Hsia et al. observed a reduction of FIB after long-term
administration of NK(18). The low dosage of NK (4 mg/day)
reversed the ischemia-induced increase in FIB concentration;
however, oral intake of high dosage NK (40 mg/day) did not.
In general, aspirin, a potent anticoagulant agent, is used for
the prevention of heart attacks, stroke and atherothrombotic
diseases. It exerts anti-platelet action by inhibiting cyclooxygenase (COX), thus reducing the synthesis of thrombogenic
thromboxane A2 (TXA2) in platelets. However, it also inhibits
COX in vascular endothelial cells and reduces the production
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Figure 3. Effects of saline and NK on (A) PT, (B) APTT, and (C) FIB
in gerbils subjected to 1 h MCAO+CCAO, followed by reperfusion for
23 h. Data were expressed as mean + SEM. Control (n = 6): pretreatment with saline for seven days; Ischemia (n = 6): 1 h MCAO+CCAO,
followed by reperfusion for 23 h; LNKI (n = 6): pretreatment with NK
(4 mg/day) for seven days and 1 h MCAO+CCAO, followed by reperfusion for 23 h; HNKI (n = 6) : pretreatment with NK (40 mg/day) for
seven days and 1 h MCAO+CCAO, followed by reperfusion for 23 h.
*p < 0.01 compared with control group; #p < 0.01 compared with ischemia group; §§p < 0.01 compared with LNKI group.
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of prostaglandin I2 (PGI2), which has anti-thrombotic effect.
Low-dose (40 mg/day) aspirin is able to reduce the formation of TXA2 in platelets, producing an inhibitory effect on
platelet aggregation, without the inhibition of PGI2 synthesis.
However, higher doses of aspirin are required to attain further
inhibition(19). In this study, the effects of low or high dosages
of NK on FIB levels may be mediated by a different pathway
similar to that of aspirin. The reason why high dosage NK did
not reverse FIB levels in cerebral ischemic model remained
unclear.
Although the neuroprotective mechanism of NK is
unclear, the in vivo cerebral ischemic model suggested that
a reduction of neuronal injury might involve thrombosis,
excessive stimulation of free radical formation, glutamate
receptors, and inflammation following focal cerebral ischemia. The brain produces free radicals during cerebral ischemia at a sufficient rate to overcome endogenous antioxidant
defenses(20). Many studies demonstrated that natto fractions
have inhibitory effect on LDL oxidation as a result of their
radical scavenging activity. Iwai et al. found that natto fractions might help to prevent arteriosclerosis, as they appear
to reduce lipid peroxidation and enhance antioxidation in
vivo(21). This may, in part, involve free radical scavenging
abilities and be beneficial to neuroprotective effects of NK in
cerebral ischemic models.

CONCLUSIONS
NK provides neuroprotective effects against focal
cerebral ischemia in a gerbil model. Reduced infarct volumes
were significant in both low and high dosage NK groups
when compared to that of the control group. PT was not
significantly different in all groups. However, low dosage NK
(4 mg/day) reversed the ischemic-induced increase in FIB
concentrations and APTT. The role of NK in the neuroprotection against cerebral ischemia remains unclear, but may
involve the alternation of fibrinolytic activity in the central
nervous system. Further investigations should be carried out
to examine the roles of NK and exact mechanisms which are
responsible for the neuroprotective effects.
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